GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Evaxion Biotech AS (NAS:EVAX) » Definitions » 12-1 Month Momentum %

EVAX (Evaxion Biotech AS) 12-1 Month Momentum % : -64.01% (As of Dec. 11, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Evaxion Biotech AS 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-12-11), Evaxion Biotech AS's 12-1 Month Momentum % is -64.01%.

The industry rank for Evaxion Biotech AS's 12-1 Month Momentum % or its related term are showing as below:

EVAX's 12-1 Month Momentum % is ranked worse than
85.46% of 1444 companies
in the Biotechnology industry
Industry Median: -13.385 vs EVAX: -64.01

Competitive Comparison of Evaxion Biotech AS's 12-1 Month Momentum %

For the Biotechnology subindustry, Evaxion Biotech AS's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Evaxion Biotech AS's 12-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Evaxion Biotech AS's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Evaxion Biotech AS's 12-1 Month Momentum % falls into.



Evaxion Biotech AS  (NAS:EVAX) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Evaxion Biotech AS  (NAS:EVAX) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Evaxion Biotech AS 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Evaxion Biotech AS's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Evaxion Biotech AS Business Description

Traded in Other Exchanges
N/A
Address
Dr. Neergaards Vej 5f, Hoersholm, DNK, DK-2970
Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.